4 analysts have expressed a variety of opinions on Masimo MASI over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Masimo Corporation MASI is well-poised for growth ... company’s shares have gained 18.4% compared with the industry’s 7.1% growth. The S&P 500 has witnessed 20.6% growth in the said time ...

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO ...

The $250 (yep, there’s no missing ‘M’ from the end of that number) Apple was awarded in its patent infringement case against Masimo might seem amusing – as John Gruber wryly noted ...

Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2024-11-05. Here's what investors need to know before the announcement. Analysts estimate that Masimo will ...

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its ...

Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo ...

Masimo (MASI) shares soared 8.7% in the last trading session to close at $121.42. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to ...

Masimo announced that its CEO Joe Kiani informed the board of directors that he has stepped down from his post. He was replaced by board member Michelle Brennan on an interim basis. The change is ...